| Product Code: ETC8198595 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Malta oral antiviral import market saw significant growth in 2024, with top exporters being India, Israel, Ireland, Germany, and Belgium. The market continues to exhibit high concentration, as indicated by the Herfindahl-Hirschman Index (HHI). The compound annual growth rate (CAGR) from 2020 to 2024 stood at a robust 10.1%, demonstrating sustained expansion. Notably, the growth rate spiked in 2024 with a notable 29.61% increase from the previous year, signaling a surge in demand for oral antiviral products in Malta.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Malta Oral Antiviral Market Overview |
3.1 Malta Country Macro Economic Indicators |
3.2 Malta Oral Antiviral Market Revenues & Volume, 2021 & 2031F |
3.3 Malta Oral Antiviral Market - Industry Life Cycle |
3.4 Malta Oral Antiviral Market - Porter's Five Forces |
3.5 Malta Oral Antiviral Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.6 Malta Oral Antiviral Market Revenues & Volume Share, By Drug class, 2021 & 2031F |
3.7 Malta Oral Antiviral Market Revenues & Volume Share, By Distribution channel, 2021 & 2031F |
4 Malta Oral Antiviral Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Malta Oral Antiviral Market Trends |
6 Malta Oral Antiviral Market, By Types |
6.1 Malta Oral Antiviral Market, By Indication |
6.1.1 Overview and Analysis |
6.1.2 Malta Oral Antiviral Market Revenues & Volume, By Indication, 2021- 2031F |
6.1.3 Malta Oral Antiviral Market Revenues & Volume, By Hepatitis, 2021- 2031F |
6.1.4 Malta Oral Antiviral Market Revenues & Volume, By Human Immunodeficiency Virus (HIV), 2021- 2031F |
6.1.5 Malta Oral Antiviral Market Revenues & Volume, By Influenza, 2021- 2031F |
6.1.6 Malta Oral Antiviral Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Malta Oral Antiviral Market, By Drug class |
6.2.1 Overview and Analysis |
6.2.2 Malta Oral Antiviral Market Revenues & Volume, By Protease inhibitors, 2021- 2031F |
6.2.3 Malta Oral Antiviral Market Revenues & Volume, By Reverse transcriptase inhibitors, 2021- 2031F |
6.2.4 Malta Oral Antiviral Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Malta Oral Antiviral Market, By Distribution channel |
6.3.1 Overview and Analysis |
6.3.2 Malta Oral Antiviral Market Revenues & Volume, By Hospital pharmacies, 2021- 2031F |
6.3.3 Malta Oral Antiviral Market Revenues & Volume, By Drug store and retail pharmacies, 2021- 2031F |
6.3.4 Malta Oral Antiviral Market Revenues & Volume, By Online providers, 2021- 2031F |
7 Malta Oral Antiviral Market Import-Export Trade Statistics |
7.1 Malta Oral Antiviral Market Export to Major Countries |
7.2 Malta Oral Antiviral Market Imports from Major Countries |
8 Malta Oral Antiviral Market Key Performance Indicators |
9 Malta Oral Antiviral Market - Opportunity Assessment |
9.1 Malta Oral Antiviral Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.2 Malta Oral Antiviral Market Opportunity Assessment, By Drug class, 2021 & 2031F |
9.3 Malta Oral Antiviral Market Opportunity Assessment, By Distribution channel, 2021 & 2031F |
10 Malta Oral Antiviral Market - Competitive Landscape |
10.1 Malta Oral Antiviral Market Revenue Share, By Companies, 2024 |
10.2 Malta Oral Antiviral Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |